Cutting Edge: DNAX Accessory Molecule 1–Deficient CD8+ T Cells Display Immunological Synapse Defects That Impair Antitumor Immunity

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Immunology

• Publication date

  2014-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1302197PMID 24337740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD226 Gly307Ser association with multiple autoimmune diseases: a meta-analysis.

  2013cited by this paper
• TACTICS, an interactive platform for customized high-content bioimaging analysis

  2013cited by this paper
• Molecular mechanisms of T cell co-stimulation and co-inhibition

  2013cited by this paper
• Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.

  2012influential reference
• Association between the CD226 rs763361 polymorphism and susceptibility to autoimmune diseases: a meta-analysis

  2012cited by this paper
• CD8 T cell defect of TNF-α and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection.

  2012influential reference
• Integrin inside-out signaling and the immunological synapse.

  2012cited by this paper
• Natural innate and adaptive immunity to cancer.

  2011cited by this paper
• CD8+ T Cells: Foot Soldiers of the Immune System

  2011cited by this paper
• Mechanical Interactions between Dendritic Cells and T Cells Correlate with T Cell Responsiveness

  2011cited by this paper
• Understanding the structure and function of the immunological synapse.

  2010cited by this paper
• Asymmetric Cell Division of T Cells upon Antigen Presentation Uses Multiple Conserved Mechanisms

  2010cited by this paper
• DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases

  2009cited by this paper
• DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

  2008cited by this paper
• Accelerated tumor growth in mice deficient in DNAM-1 receptor

  2008cited by this paper
• Both CD133+ and CD133– medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK‐mediated cytotoxicity

  2007cited by this paper
• The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.

  2006cited by this paper
• Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation

  2006cited by this paper
• LFA-1-dependent lipid raft recruitment of DNAM-1 (CD226) in CD4+ T cell.

  2006cited by this paper
• Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226).

  2005cited by this paper
• A network of PDZ-containing proteins regulates T cell polarity and morphology during migration and immunological synapse formation.

  2005cited by this paper
• The LFA-1-associated Molecule PTA-1 (CD226) on T Cells Forms a Dynamic Molecular Complex with Protein 4.1G and Human Discs Large*

  2004cited by this paper
• CD226 (DNAM-1) Is Involved in Lymphocyte Function–associated Antigen 1 Costimulatory Signal for Naive T Cell Differentiation and Proliferation

  2003cited by this paper
• Physical and functional association of LFA-1 with DNAM-1 adhesion molecule.

  1999cited by this paper
• LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor

  1996cited by this paper

• TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength

  2026cites this paper
• CD226/TIGIT: candidates for new allergy treatments

  2025cites this paper
• PVR exposure influences the activation, adhesion, and protein expression of human CD8+ T cells, including the CD96-mediated transfer of PVR.

  2025cites this paper
• Impact of immune checkpoint TIGIT on the activation and function of natural killer cells in rheumatoid arthritis patients.

  2025cites this paper
• Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2

  2024cites this paper
• The PD-1/PD-L1 Axis in the Biology of MASLD

  2024cites this paper
• Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?

  2024cites this paper
• Immunotherapy in cancer: Where we are and what the future brings?

  2023cites this paper
• Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials

  2023cites this paper
• Nectin Family Ligands Trigger Immune Effector Functions in Health and Autoimmunity

  2023cites this paper
• TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy

  2022cites this paper
• NKG7 Enhances CD8+ T Cell Synapse Efficiency to Limit Inflammation

  2022cites this paper
• Therapeutic Targeting of Checkpoint Receptors within the DNAM-1 Axis.

  2021cites this paper
• Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma

  2021cites this paper
• Immunotherapy in multiple myeloma.

  2021cites this paper
• TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma

  2021cites this paper
• IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma

  2020cites this paper
• A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals

  2020cites this paper
• CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.

  2020cites this paper
• Targeting novel inhibitory receptors in cancer immunotherapy.

  2020cites this paper
• Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy

  2020cites this paper
• TIGIT in cancer immunotherapy

  2020cites this paper
• Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1

  2019cites this paper
• Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity

  2019cites this paper
• CD226 opposes TIGIT to disrupt Tregs in melanoma.

  2018cites this paper
• NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27

  2017cites this paper
• EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity

  2017cites this paper
• T cell exhaustion: from pathophysiological basics to tumor immunotherapy

  2017cites this paper
• Cd226−/− natural killer cells fail to establish stable contacts with cancer cells and show impaired control of tumor metastasis in vivo

  2017cites this paper
• TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia

  2017cites this paper
• Evaluation of novel anti-tumoral strategies using peptide or monoclonal antibody immunotherapies

  2016cites this paper
• Lethal giant larvae‐1 deficiency enhances the CD8+ effector T‐cell response to antigen challenge in vivo

  2016cites this paper
• Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus Infection

  2016cites this paper
• Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing

  2016cites this paper
• Regulation of Immune Cell Functions through Nectin and Nectin-Like Receptors

  2016cites this paper
• Coordinated Expression of DNAM-1 and LFA-1 in Educated NK Cells

  2015cites this paper
• Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators

  2015cites this paper
• The Role of the immunological Synapse Formed by Cytotoxic Lymphocytes in Immunodeficiency and Anti-Tumor immunity.

  2015cites this paper
• Balancing natural killer cell activation through paired receptors

  2015cites this paper
• Newtonian cell interactions shape natural killer cell education

  2015cites this paper
• Immunosurveillance and therapy of multiple myeloma are CD226 dependent.

  2015cites this paper
• Immunosurveillance and therapy of multiple myeloma are CD226 dependent.

  2015cites this paper
• DNAM-1 expression marks an alternative program of NK cell maturation.

  2015cites this paper
• Increased CD226 Expression on CD8+ T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis

  2015cites this paper
• Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.

  2015cites this paper
• Critical roles of co‐activation receptor DNAX accessory molecule‐1 in natural killer cell immunity

  2015cites this paper
• TACTICS for bioimaging informatics and analysis of T Cells

  2014cites this paper
• The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function.

  2014cites this paper
• Beneficial Autoimmunity at Body Surfaces – Immune Surveillance and Rapid Type 2 Immunity Regulate Tissue Homeostasis and Cancer

  2014cites this paper
• Normalized Polarization Ratios for the Analysis of Cell Polarity

  2014cites this paper
• Lfa-1 in Educated Nk Cells Coordinated Expression of Dnam-1 And

  year unknowncites this paper